Generated: December 18, 2017
DrugPatentWatch Database Preview
Details for Patent: 4,777,163
« Back to Dashboard
Summary for Patent: 4,777,163
|Title:|| Diphosphonate derivatives, pharmaceutical compositions and methods of use for calcium disturbances|
|Abstract:||The present invention produces alkyldiphosphonic acid derivative of the general formula: ##STR1## wherein Het is a heteroaromatic five-membered ring containing to 3 heteroatoms which can be partly hydrogenated and optionally substituted one or more times by alkyl, alkoxy, phenyl, cyclohexyl, cyclohexylmethyl, halogen or amino, and two adjacent alkyl substituents can together also form a ring, Y is a hydrogen atom or a lower alkyl radical, X is a hydrogen atom, a hydroxyl group or an amino group optionally substituted by lower alkyl and R is a hydrogen atom or a lower alkyl radical, with the proviso that Het is not a pyrazole ring; as well as the pharmacologically acceptable salts thereof. The present invention also provides processes for the prepearation of these compounds and pharmaceutical compositions containing them useful for the treatment or prophylaxis of calcium metabolism disturbances or disease as for example osteoporosis, Bechterew's disease, bone metastases, urolithiasis, heterotropic ossifications, rheumatoid arthritis osteoarthritis or degenerative arthrosis.|
|Inventor(s):|| Bosies; Elmar (Weinheim, DE), Gall; Rudi (Hirschberg, DE) |
|Assignee:|| Boehringer Mannheim GmbH (Mannheim, DE) |
Patent Claim Types:|
see list of patent claims
|Compound; Use; Composition; |
No matches for this query
Foreign Priority and PCT Information for Patent: 4,777,163
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Germany||3626058||Aug 01, 1986|
International Patent Family for Patent: 4,777,163
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.